ReviewChemistry & biodiversity2026
Advances in the Preparation, Characterization, and Bioactivity of Oligosaccharides From Traditional Chinese Medicine Polysaccharides: A Comprehensive Review.
Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Polysaccharides in traditional Chinese medicine (TCM) are essential compounds responsible for therapeutic effects, exhibiting immunomodulatory, anti-inflammatory, and antioxidant properties. However, their high molecular weight, low solubility, and poor bioavailability restrict clinical application. Degrading these into smaller, absorbable TCM oligosaccharides (TCMOs) not only overcomes these barriers but may also enhance biological activity, offering a new avenue for high-value TCM development. This review summarizes the progress in preparing TCMOs using chemical, physical, and enzymatic methods. It outlines techniques for the separation, purification, and structural characterization of degradation products, while examining the biological activities of TCMOs in regulating gut microbiota and enhancing immunity. Enzymatic hydrolysis is established as a superior strategy for precision degradation due to its specificity and tunable kinetics. Leveraging gut microbiota-derived Polysaccharide Utilization Loci (PULs) for "bio-intelligent" preparation represents a transformative frontier for generating structurally defined TCMOs. For isolation, chromatographic platforms remain the most versatile methodologies. While the immunomodulatory effects of TCMOs are well-documented, a critical gap remains concerning structure-activity relationships in antitumor pathways and metabolic absorption. By synthesizing these insights, this review facilitates the precision customization and industrial advancement of bioactive TCMOs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.